Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Thyroid Neoplasms 1Thoracic Neoplasms 1Solid Tumors 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Neoplasms, Nerve Tissue 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Lung Diseases 1Head and Neck Neoplasms 1Carcinoma, Bronchogenic 1Carcinoma 1Bronchial Diseases 1Advanced Thyroid Cancer Patients Who Received Target Therapy 1Adenocarcinoma 1

Interventions

Carboplatin 7Paclitaxel 4Cisplatin 4pembrolizumab 3Pemetrexed 3zipalertinib 2selpercatinib 2durvalumab 2Nivolumab 2Blood Specimen Collection 2zimberelimab 1taletrectinib 1sotorasib 1sacituzumab govitecan 1repotrectinib 1pralsetinib 1ceralasertib 1cemiplimab 1atezolizumab 1alectinib 1Tomography, Emission-Computed, Single-Photon 1Toll-Like Receptor 1 1Telescopes 1Surveys and Questionnaires 1Radiosurgery 1One-Lung Ventilation 1Omacor 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Health Records, Personal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases × pralsetinib × 1 year × Clear all
NCT04222972 2026-03-05

AcceleRET-Lung

Hoffmann-La Roche

Phase 3 Terminated
223 enrolled 18 charts
Head & NeckThoracic

Adenocarcinoma, Bronchial Diseases, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡